US Patent

US7700076 — Penetrating pharmaceutical foam

Formulation · Assigned to Foamix Ltd · Expires 2027-09-18 · 1y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a formulation of an alcohol-free cosmetic or pharmaceutical foam composition that enhances skin penetration.

USPTO Abstract

The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.

Drugs covered by this patent

Patent Metadata

Patent number
US7700076
Jurisdiction
US
Classification
Formulation
Expires
2027-09-18
Drug substance claim
No
Drug product claim
Yes
Assignee
Foamix Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.